RUA Life Sciences (LON:RUA) Announces Quarterly Earnings Results

RUA Life Sciences (LON:RUA) issued its earnings results on Tuesday. The company reported GBX (0.33) EPS for the quarter, Digital Look Earnings reports. The firm had revenue of GBX 275 million during the quarter. RUA Life Sciences had a negative return on equity of 2.03% and a negative net margin of 3.26%.

RUA Life Sciences Trading Up 4.7%

Shares of RUA opened at GBX 19.90 on Wednesday. The stock has a fifty day moving average price of GBX 19.93 and a two-hundred day moving average price of GBX 15.89. The company has a debt-to-equity ratio of 18.95, a quick ratio of 7.32 and a current ratio of 4.64. RUA Life Sciences has a 52-week low of GBX 10.42 and a 52-week high of GBX 26.80. The company has a market cap of £12.35 million, a price-to-earnings ratio of -2.61 and a beta of 0.96.

RUA Life Sciences Company Profile

The RUA Life Sciences group was created in April 2020 when AorTech International plc acquired RUA Medical Devices Ltd to create a fully formed medical device business. RUA Life Sciences is the holding company of the group trading through four businesses all exploiting the group’s polymer technology. Our vision is to improve the lives of millions of patients by improving and enabling medical devices with Elast-EonTM, the worlds leading long term implantable polyurethane.